Free Trial

LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular logo
$89.75 +1.74 (+1.98%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$89.75 0.00 (0.00%)
As of 05:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LMAT vs. STVN, IRTC, BLCO, GKOS, TMDX, SLNO, NVST, LIVN, WRBY, and INSP

Should you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

LeMaitre Vascular vs. Its Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

In the previous week, LeMaitre Vascular had 4 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 4 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.36 beat LeMaitre Vascular's score of 0.63 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LeMaitre Vascular
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group€1.19B6.68€127.45M€0.5448.79
LeMaitre Vascular$219.86M9.24$44.04M$2.0643.57

Stevanato Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

LeMaitre Vascular has a net margin of 20.08% compared to Stevanato Group's net margin of 11.73%. LeMaitre Vascular's return on equity of 13.67% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group11.73% 10.34% 6.21%
LeMaitre Vascular 20.08%13.67%9.14%

LeMaitre Vascular has a consensus target price of $97.60, indicating a potential upside of 8.75%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71
LeMaitre Vascular
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

84.6% of LeMaitre Vascular shares are owned by institutional investors. 9.5% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

LeMaitre Vascular beats Stevanato Group on 10 of the 16 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMAT vs. The Competition

MetricLeMaitre VascularMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.99B$11.03B$6.22B$10.67B
Dividend Yield0.91%1.87%5.74%4.88%
P/E Ratio43.5720.3929.1527.23
Price / Sales9.2428.12589.23132.71
Price / Cash36.8425.0537.5161.65
Price / Book5.983.4912.386.59
Net Income$44.04M$208.83M$3.32B$276.14M
7 Day Performance2.85%-1.92%0.75%-0.72%
1 Month Performance-2.75%0.07%7.29%2.47%
1 Year Performance2.84%-8.95%62.62%33.90%

LeMaitre Vascular Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LMAT
LeMaitre Vascular
3.2535 of 5 stars
$89.75
+2.0%
$97.60
+8.7%
+1.3%$1.99B$219.86M43.57490
STVN
Stevanato Group
N/A€23.33
-2.2%
N/A+44.7%€7.07B€1.19B43.205,521News Coverage
IRTC
iRhythm Technologies
1.5541 of 5 stars
$177.37
+0.7%
$180.23
+1.6%
+186.9%$5.66B$591.84M-60.542,000Positive News
BLCO
Bausch + Lomb
1.4058 of 5 stars
$14.87
+3.8%
$15.70
+5.6%
-24.3%$5.07B$4.79B-19.0613,500News Coverage
Upcoming Earnings
GKOS
Glaukos
4.5496 of 5 stars
$83.11
+0.7%
$116.92
+40.7%
-42.7%$4.73B$383.48M-50.37780Trending News
Upcoming Earnings
Analyst Forecast
TMDX
TransMedics Group
2.5043 of 5 stars
$111.71
+4.1%
$127.18
+13.8%
-3.5%$3.66B$441.54M57.88210Upcoming Earnings
SLNO
Soleno Therapeutics
4.3124 of 5 stars
$64.27
+0.8%
$115.92
+80.4%
+24.9%$3.39BN/A-15.5230
NVST
Envista
3.6081 of 5 stars
$19.23
+0.9%
$21.08
+9.6%
+8.1%$3.17B$2.51B60.1012,300
LIVN
LivaNova
2.8667 of 5 stars
$51.78
+2.2%
$59.71
+15.3%
+3.7%$2.77B$1.25B-13.312,900
WRBY
Warby Parker
2.343 of 5 stars
$22.17
-0.4%
$24.75
+11.7%
+19.4%$2.34B$821.35M-316.613,780Positive News
Gap Up
INSP
Inspire Medical Systems
4.7795 of 5 stars
$77.57
+3.2%
$150.50
+94.0%
-59.2%$2.22B$802.80M44.841,246

Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners